 CRANFORD, N.J., Oct. 25, 2021 PRNewswire -- Citius Pharmaceuticals, Inc. Citius or the Company Nasdaq: CTXR, a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies, today announced that it will host a key opinion leader KOL webinar on the compelling need to salvage central venous catheters in patients with central line associated blood stream infections CLABSI on Thursday, November 11, 2021 at 11:30am Eastern Time. 